Germany· DE-A57-fa4e657bb2fe6b49
Fraxiparine
A nadroparin product containing nadroparin calcium, registered in Germany by Viatris Healthcare Gmbh. The same ATC class is registered in 8 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Nadroparin is registered in 8 of 19 countries.
Countries holding a registration under ATC B01AB06 (nadroparin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 6 of them publish a price we can compare per daily dose
Nadroparin · ATC B01AB06
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Nadroparin Calcium
- Manufacturer
- Viatris Healthcare Gmbh
- Country
- Germany (DE)
- ATC code
- B01AB06
- ATC class
- Nadroparin
- Defined daily dose
- 2.85 TSD, E
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nadroparin in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFRAXIPARINEVIATRIS HEALTHCARE LIMITED, Dublin
- BelgiumFraxiparine 2850 IU (Anti-Xa)/0,3 mlViatris Healthcare
- FinlandFraxiparineGlaxoSmithKline Oy
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Fraxiparin
- Belgium · Fraxiparine, Fraxodi
- Bulgaria · Фраксипарин
- Czechia · Fraxiparine, Fraxiparine Forte
- Estonia · Fraxiparine
- France · Fraxiparine, Fraxodi
- Greece · Fraxiparine
- Croatia · Fraxiparine
- Hungary · Fraxiparine, Fraxodi
- Italy · Seledie, Seleparina
- Lithuania · Fraxiparine
- Luxembourg · Fraxiparine, Fraxodi
- Latvia · Fraxiparine
- Netherlands · Fraxiparine, Fraxiparine Forte
- Poland · Fraxiparine, Fraxodi
- Romania · Fraxiparine
- Slovenia · Fraxiparine, Fraxiparine Forte
- Slovakia · Fraxiparine, Fraxiparine Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4785b4b6-b88d-4d97-91c1-7cf72e99010c GET /v1/drugs/4785b4b6-b88d-4d97-91c1-7cf72e99010c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Nadroparin Calcium",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about nadroparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.